🚀 Breaking News: Introducing Health Tech Pathways 🚀 We’re thrilled to announce a new, major project in the works: Health Tech Pathways - an AI-powered platform designed to help Nordic #healthtech startups navigate the regulatory approval process faster and more cost-effectively. With a generous DKK 32 million from the Novo Nordisk Foundation over five years, we’re building a platform that will transform how health tech startups approach certification in the EU and the U.S., significantly reducing both the costs and timelines associated with obtaining approvals. Health tech startups face the hurdle of lengthy and complex regulatory approval processes delaying their ability to bring innovative solutions to market. Here’s how the platform will support them: ✨ Learning Resources – Access to training on regulatory pathways and legislation ✨ Approval Guidance – Tools for risk assessment and certification pathways ✨ Regulatory Community – Connect with peers and industry consultants ✨ AI Assistance – AI-powered support for Q&A’s, and, in the future, for writing and validating regulatory documentation Martin Broch Pedersen, Business Development Director at #HTHC, says, “We need to have a place where startups can find the right resources, training, and support for faster, more efficient market entry.” Health Tech Pathways will empower Nordic and European innovators, streamlining their path to regulatory success and help them make significant impact on health and healthcare. Thank you to the Novo Nordisk Foundation for supporting Health Tech Pathways! Find out more about the project: https://lnkd.in/dgAWb8dY where you can sign up for project updates and connect with the team behind the solution. #regulatoryapprovals #cemark #digitalhealth Mikkel Bülow Skovborg | Signe Daugbjerg, PhD | Jesper Grønbæk | Arkan Vasie | Ellen de Bever | Anett Falussy | Jannik Topgaard Zeuthen | Nicolas Bouchet | Oded Yair Menuhin | Line Rasmussen | Line Knoop-Henriksen | Giulia Galimberti | Mafalda Camara
Health tech startups often struggle with lengthy and complex regulatory approval processes, delaying their ability to bring innovative solutions to market. To address this challenge, the Novo Nordisk Foundation is supporting non-profit organisation Health Tech Hub Copenhagen with a grant of DKK 32 million to develop Health Tech Pathways. This AI-powered platform will simplify the regulatory journey for Nordic health tech startups, providing a clearer and faster pathway to approval. Health Tech Pathways aims to substantially reduce the current approval time in Europe, which is 13-18 months, thereby accelerating access to cutting-edge health technologies for patients. For more information and updates, please visit: www.healthtechpathways.org